{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:02:23Z","timestamp":1774713743771,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,28]]},"DOI":"10.7759\/cureus.106024","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:40:21Z","timestamp":1774712421000},"source":"Crossref","is-referenced-by-count":0,"title":["Unexplained Inguinal Adenopathy Leading to the Diagnosis of Metastatic High-Grade Serous Ovarian Carcinoma"],"prefix":"10.7759","author":[{"given":"Olivia R","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan W","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peighton E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio MA","year":"2019","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019, 20:952. 10.3390\/ijms20040952","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1539024","article-title":"The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer","volume":"12","author":"Deng M","year":"2025","unstructured":"Deng M, Yang R, Jiang J, Zhang J, He J, Miao J. The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer. Front Med (Lausanne). 2025, 12:1539024. 10.3389\/fmed.2025.1539024","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman RJ","year":"2016","unstructured":"Kurman RJ, Shih IeM. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016, 186:733-47. 10.1016\/j.ajpath.2015.11.011","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-017-4529-z","article-title":"Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?","volume":"296","author":"Klotz DM","year":"2017","unstructured":"Klotz DM, Wimberger P. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?. Arch Gynecol Obstet. 2017, 296:1055-62. 10.1007\/s00404-017-4529-z","journal-title":"Arch Gynecol Obstet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102371","article-title":"Occult ovarian high-grade serous carcinoma presenting as isolated inguinal lymph node metastasis: a case report and literature review","volume":"55","author":"Guan X","year":"2025","unstructured":"Guan X, Ma Z, Yang J. Occult ovarian high-grade serous carcinoma presenting as isolated inguinal lymph node metastasis: a case report and literature review. Transl Oncol. 2025, 55:102371. 10.1016\/j.tranon.2025.102371","journal-title":"Transl Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel E","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010, 177:1053-64. 10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213777","article-title":"Molecular management of high-grade serous ovarian carcinoma","volume":"23","author":"Punz\u00f3n-Jim\u00e9nez P","year":"2022","unstructured":"Punz\u00f3n-Jim\u00e9nez P, Lago V, Domingo S, Sim\u00f3n C, Mas A. Molecular management of high-grade serous ovarian carcinoma. Int J Mol Sci. 2022, 23:13777. 10.3390\/ijms232213777","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-016-0157-9","article-title":"Update on imaging of ovarian cancer","volume":"4","author":"Forstner R","year":"2016","unstructured":"Forstner R, Meissnitzer M, Cunha TM. Update on imaging of ovarian cancer. Curr Radiol Rep. 2016, 4:31. 10.1007\/s40134-016-0157-9","journal-title":"Curr Radiol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2019.01.007","article-title":"Ovarian high-grade serous carcinoma: assessing pathology for site of origin, staging and post-neoadjuvant chemotherapy changes","volume":"12","author":"Casey L","year":"2019","unstructured":"Casey L, Singh N. Ovarian high-grade serous carcinoma: assessing pathology for site of origin, staging and post-neoadjuvant chemotherapy changes. Surg Pathol Clin. 2019, 12:515-28. 10.1016\/j.path.2019.01.007","journal-title":"Surg Pathol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000514","article-title":"Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer","volume":"25","author":"Kleppe M","year":"2015","unstructured":"Kleppe M, Kraima AC, Kruitwagen RF, Van Gorp T, Smit NN, van Munsteren JC, DeRuiter MC. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer. 2015, 25:1405-14. 10.1097\/IGC.0000000000000514","journal-title":"Int J Gynecol Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2017.01.003","article-title":"Ovarian cancer with metastatic inguinal lymphadenopathy: a case series and literature review","volume":"29","author":"Metwally IH","year":"2017","unstructured":"Metwally IH, Zuhdy M, Hassan A, Alghandour R, Megahed N. Ovarian cancer with metastatic inguinal lymphadenopathy: a case series and literature review. J Egypt Natl Canc Inst. 2017, 29:109-14. 10.1016\/j.jnci.2017.01.003","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.124","article-title":"Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?","volume":"147","author":"Nasioudis D","year":"2017","unstructured":"Nasioudis D, Chapman-Davis E, Frey MK, Caputo TA, Witkin SS, Holcomb K. Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?. Gynecol Oncol. 2017, 147:81-4. 10.1016\/j.ygyno.2017.07.124","journal-title":"Gynecol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/475670-unexplained-inguinal-adenopathy-leading-to-the-diagnosis-of-metastatic-high-grade-serous-ovarian-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:40:22Z","timestamp":1774712422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/475670-unexplained-inguinal-adenopathy-leading-to-the-diagnosis-of-metastatic-high-grade-serous-ovarian-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.106024","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}